J
Jukka Kallijärvi
Researcher at University of Helsinki
Publications - 40
Citations - 1169
Jukka Kallijärvi is an academic researcher from University of Helsinki. The author has contributed to research in topics: Mulibrey nanism & Respiratory chain. The author has an hindex of 17, co-authored 35 publications receiving 846 citations.
Papers
More filters
Journal ArticleDOI
A sensitive assay for dNTPs based on long synthetic oligonucleotides, EvaGreen dye and inhibitor-resistant high-fidelity DNA polymerase.
TL;DR: A simple non-radioactive microplate assay for the quantification of dNTPs with a minimum requirement of 4–12 mg of biopsy material based on long synthetic single-stranded DNA templates, an inhibitor-resistant high-fidelity DNA polymerase, and the double-strander-DNA-binding EvaGreen dye that quantified reliably and discriminated well against ribonucleotides.
Journal ArticleDOI
TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase.
Jukka Kallijärvi,Ulla Lahtinen,Riikka H. Hämäläinen,Marita Lipsanen-Nyman,Jorma J. Palvimo,Jorma J. Palvimo,Anna-Elina Lehesjoki +6 more
TL;DR: It is suggested that TRIM37 acts as a TRIM domain-dependent E3 ubiquitin ligase and imply defective ubiquit in-dependent degradation of an as-yet-unidentified target protein in the pathogenesis of mulibrey nanism.
Journal ArticleDOI
The TRIM37 Gene Encodes a Peroxisomal RING-B-Box-Coiled-Coil Protein: Classification of Mulibrey Nanism as a New Peroxisomal Disorder
TL;DR: Molecular evidence unequivocally indicates that TRIM37 is located in the peroxisomes, and mulibrey nanism thus can be classified as a newPeroxisomal disorder.
Journal ArticleDOI
RNAi screening for kinases and phosphatases identifies FoxO regulators.
TL;DR: Several currently known dFoxO regulators were found in the screening, confirming the validity of the approach and several interesting new regulators were identified, including protein kinase C and glycogen synthase kinase 3β, two proteins with important roles in insulin signaling.
Journal ArticleDOI
Alternative oxidase-mediated respiration prevents lethal mitochondrial cardiomyopathy
Jayasimman Rajendran,Janne Purhonen,Saara Tegelberg,Saara Tegelberg,Olli-Pekka Smolander,Matthias Mörgelin,Jan Rozman,Valerie Gailus-Durner,Helmut Fuchs,Martin Hrabé de Angelis,Petri Auvinen,Eero Mervaala,Howard T. Jacobs,Howard T. Jacobs,Marten Szibor,Marten Szibor,Vineta Fellman,Vineta Fellman,Jukka Kallijärvi +18 more
TL;DR: The value of AOX is demonstrated, both as a mechanistic tool and a potential therapeutic strategy, for cIII deficiencies, showing that the restored electron flow upstream of cIII was sufficient to prevent cardiac energetic crisis and detrimental decompensation.